Xtrackers FTSE Developed ex US Multifactor ETF
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company.
AI analysis
An AI analyst reads Xtrackers FTSE Developed ex US Multifactor ETF's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- +9.9%
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
News
Which Global Real Estate ETF Is the Better Buy: State Street’s RWO or Xtrackers’ HAUZ?Yahoo Finance · Oct 12, 2026Vanguard's VNQI or Xtrackers' HAUZ: Which Real Estate ETF Fits Your Stage?Yahoo Finance · Aug 22, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Xtrackers FTSE Developed ex US Multifactor ETF
Is Xtrackers FTSE Developed ex US Multifactor ETF a good stock to buy?
A fund that holds many companies, so profit, growth, price and debt are not measured for it as for one company. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Xtrackers FTSE Developed ex US Multifactor ETF AI analysis
What does Xtrackers FTSE Developed ex US Multifactor ETF do?
Xtrackers FTSE Developed ex US Multifactor ETF (the “Fund”) seeks investment results that correspond generally to the performance, before fees and expenses, of the FTSE Developed ex US Comprehensive Factor Index (the “Underlying Index”). It is in Asset Management.
How has Xtrackers FTSE Developed ex US Multifactor ETF stock done over the past year?
Up 13.5% over the past twelve months, to $39.79. It traded between $33.95 and $41.12 and is 3.3% below its high.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.